India Today on MSN

FDA flags rare eye-stroke risk across GLP-1 drugs as Indian use surges

The FDA has ordered GLP-1 drug labels to flag a potential risk of NAION. The move sharpens scrutiny as cheaper weight-loss medicines reach more Indian patients.

Rare Earth Price Gap Flags Supply Strains Ahead of Trump-Xi Meet

A global rush to secure strategic metals is taking on new urgency ahead of a possible meeting of the US and Chinese leaders ...

Rare Pitru Dosh remedies window: Mars, Jupiter, Ketu align in Magha; astrologers flag 2026 dates

During the period from 12 November to 5 December 2026, the universe is abuzz with important astrological activities, notably ...

How Russell Brand Got Caught

A once-deified celebrity who lured women under the guise of humor has been jailed for 10 years. Here, two sexual assault ...

The Next Chapter of mRNA

Inside the new manufacturing site for intismeran, a personalized mRNA-based cancer vaccine at Moderna in Marlborough, ...
Türkiye Today

FDA flags rare side effect on Ozempic, Zepbound labels

FDA asks GLP-1 drugmakers to add label warning of rare eye condition that can cause sudden, permanent vision loss ...

US FDA flags blindness risk from GLP-1 drugs: What patients should know

The US regulator has called for new eye-related warnings on GLP-1 drug labels, but Indian safety data remains limited ...

'Fully and immediately': US urges China to honour trade commitments, flags concerns over rare earths and farm purchases

The US has urged China to honour its trade commitments on agricultural purchases, rare earths and critical minerals, warning ...

FDA flags potential vision loss risk linked to GLP-1 drugs: What users of weight-loss medications should know

FDA analysis of 126 clinical trials involving 134,253 participants found higher NAION incidence among GLP-1 drug users than ...